Treatment News : HPV Vaccine Could Reduce Anal Cancer Rates in Older Gay Men

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » July 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

July 18, 2013

HPV Vaccine Could Reduce Anal Cancer Rates in Older Gay Men

Human papillomavirus (HPV) vaccines, given to older gay men, could prevent the transmission of strains of the virus that lead to anal cancer, aidsmap reports. Between 2010 and 2013, Australian researchers studied 342 gay men ages 35 or older who were tested at the outset for the strains of HPV covered by the currently available Gardasil vaccine and by the vaccine in development by Merck. They presented their findings at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) in Kuala Lumpur.

Anal cancer is particularly prevalent among HIV-positive gay men, who have a rate of 100 cases per 100,000 people.

The study population had a median age of 49, with a range of 35 to 79. Twenty-nine percent of them were HIV positive. Over a three-year follow-up period, the participants were tested for new high-risk HPV infections.

At the study’s outset, 51 percent of the men were infected with a Gardasil-covered strain of HPV and 27 percent with the Merck vaccine-covered strains. Each year of the study, one in five men became newly infected with a strain covered by Gardasil and 27 percent with a strain covered by Merck’s vaccine.

Having HIV was linked both to infection with cancer-causing HPV at the study’s outset and to new infections with those strains during the follow-up period. There was no correlation between age and likelihood of HPV infection.

To read the aidsmap story, click here.

Search: HPV, vaccine, Gardasil, anal cancer, aidsmap, human papillomavirus, th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Merck & Co.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


         


[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    dlw8585
    Fort Lauderdale
    Florida


    romanticseattle
    Tacoma
    Washington


    youngbloodlatino
    Columbia
    Maryland


    pozsmith1
    East Bay
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Can social media help stop HIV stigma?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.